Search Our Scientific Publications & Authors

Aesthet Surg J 2019 Feb 21. Epub 2019 Feb 21.

Toxin Science Limited, Wrexham, UK.

Aesthet Surg J 2019 Feb 21. Epub 2019 Feb 21.

Department of Pathology, University of Cambridge, and the Department of Histopathology, Addenbrooke's Hospital, Cambridge, UK.

Aesthet Surg J 2019 Feb 21. Epub 2019 Feb 21.

Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX.

Background: Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is an uncommon type of non-Hodgkin lymphoma occurring in the fluid or capsule adjacent to textured breast implants. Diagnosis of BIA-ALCL of symptomatic patients requires demonstration of large anaplastic cells with uniform expression of CD30 protein on immunohistochemistry.

Objective: The authors investigated a novel, rapid, office-based, and economic in-situ enzyme-linked immunosorbent assay (ELISA) for screening BIA-ALCL patients. Read More

Aesthet Surg J 2019 Feb 4. Epub 2019 Feb 4.

Private practice in Paris, France.

Background: The lips are a focal point of the face; however, their aesthetic proportions and effect on perceived facial beauty remain poorly defined. Perioral ageing is highly individual, with several distinct and often simultaneous processes contributing to changes in lip contour and surface. These processes can affect lip volume and length, shape, and the degree of vermilion inversion. Read More

Aesthet Surg J 2019 Feb 3. Epub 2019 Feb 3.

Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.

Background: The Breast-Q Implant Surveillance (BREAST-Q IS) is a patient-reported outcome measure (PROM) asking five questions on satisfaction (shape, feel, and rippling) and symptoms (pain and tightness) derived from the BREAST-Q.

Objectives: We aimed to pilot BREAST-Q IS on patients within the Australian Breast Device Registry (ABDR), an opt-out clinical quality device registry, and explored Short Message Service (SMS) for follow up.

Methods: Patients with a breast device surgery in the previous 10-15 months, age ≥18, with a mobile phone number, were invited to complete the 5-question PROM via SMS initially, followed by three phone call attempts if no response, an email, and then a letter by post as a final engagement strategy. Read More

Aesthet Surg J 2019 Feb 19. Epub 2019 Feb 19.

Private practice in Seoul, Korea.

Background: During aging, facial skin thins, atrophies, and loses elasticity. Subdermal filler injections can volumize and treat wrinkles but cannot directly change dermal thickness. Polycaprolactone (PCL)-fillers can improve skin texture and quality through dermal thickening and inducing neocollagenesis. Read More

Aesthet Surg J 2019 Feb;39(3):NP34-NP35

Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI.

Aesthet Surg J 2019 Feb;39(3):NP32-NP33

Department of Plastic Surgery, Plastic Surgery Hospital, Chinese Academy of Medical Science, Beijing, PR China.

Aesthet Surg J 2019 Feb;39(3):248-253

Dr Wu is a plastic surgeon in private practice in Singapore.

Aesthet Surg J 2019 Feb;39(3):343-347

Plastic surgery practice in Stockholm, Sweden.

Aesthet Surg J 2019 Feb 15. Epub 2019 Feb 15.

Keck Hospital of University of Southern California, Los Angeles, CA.

Anaplastic large-cell lymphoma (ALCL) is a very rare but life-threatening complication that has largely been demonstrated to be associated with breast implants (BIA-ALCL). Patients are at risk of BIA-ALCL with the placement of breast implants for either cosmetic or reconstructive purposes, with the highest risks associated with textured breast implants. In the past decade, there have been an increasing number of publications focused on BIA-ALCL, but there has yet to be a reported case outside of the breast. Read More

Aesthet Surg J 2019 Feb 15. Epub 2019 Feb 15.

North Charleston, SC.

Background: Sub-SMAS rhytidectomy techniques are considered to have a higher complication profile, especially for facial nerve injury, when compared to less invasive SMAS techniques. This results in surgeons avoiding sub-SMAS dissection.

Objective: Aggregate and summarize data on complications among different SMAS facelift techniques. Read More

Aesthet Surg J 2019 Feb 15. Epub 2019 Feb 15.

Department of Plastic and Reconstructive Surgery, Hospital General Dr. Ruben Leñero, Mexico City, Mexico.

Background: Buccal fat pad excision is a procedure in which the fat pad is extracted in order to achieve a more youthful appearance.

Objectives: To describe an alternative technique that utilizes hydrodissection as a means to extract the buccal fat pad.

Methods: This is a controlled, prospective, randomized clinical study with two groups. Read More

Aesthet Surg J 2019 Feb 14. Epub 2019 Feb 14.

Aesthet Surg J 2019 Feb 13. Epub 2019 Feb 13.

The Head of Plastic and Reconstructive Surgery, Macquarie University, Sydney, Australia.

Aesthet Surg J 2019 Feb 12. Epub 2019 Feb 12.

UC Irvine Center for Tissue Engineering, UC Irvine Department of Plastic Surgery, Center for Tissue Engineering, Orange, CA.

Mixed reality, a blending of the physical and digital worlds, can enhance the surgical experience, leading to greater precision, efficiency and improved outcomes. Various studies across different disciplines have reported encouraging results using mixed reality technologies, such as augmented and virtual reality. To provide a better understanding of the applications and limitations of this technology in plastic surgery, we performed a systematic review of the literature in accordance with PRISMA guidelines. Read More

Aesthet Surg J 2019 Feb 8. Epub 2019 Feb 8.

Professor of Plastic Surgery, Virginia Commonwealth University-Inova Branch, Falls Church, VA.

Aesthet Surg J 2019 Feb 11. Epub 2019 Feb 11.

Department of Surgery, Emory University School of Medicine, Atlanta GA.

Aesthet Surg J 2019 Feb 12. Epub 2019 Feb 12.

Plastic surgeon in private practice in Leawood, KS.

Aesthet Surg J 2019 Feb 12. Epub 2019 Feb 12.

Attending Physician, Division of Plastic and Reconstructive Surgery, Department of Surgery, Metrohealth Medical Center, Cleveland, OH.

Aesthet Surg J 2019 Feb 12. Epub 2019 Feb 12.

Private practice in Rome, Italy.

Background: The main challenge of periocular fat grafting is the risk of contour irregularities, especially in the lower eyelid. Injection of diluted fat can decrease the likelihood of poor contour.

Objectives: The authors developed a simple method of periocular fat grafting in which the fat was harvested through unconventional cannulas and diluted before the injection to avoid the risk of contour irregularities. Read More

Aesthet Surg J 2019 Feb 7. Epub 2019 Feb 7.

National Health and Medical Research Council Early Career Fellow and Clinical Psychologist (Registrar), Monash University, Melbourne, Victoria, Australia.

Aesthet Surg J 2019 Feb 5. Epub 2019 Feb 5.

Department of Plastic Surgery, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.

Multiple patientreported outcome measures (PROMs) are available to assess patient satisfaction after rhinoplasty. These selfassessment measures can be divided into 3 categories: measures for functional outcomes, aesthetic outcomes, and both. Although Barone et al have discussed this classification, a recently developed scale was not featured. Read More

Aesthet Surg J 2019 Feb 5. Epub 2019 Feb 5.

Yale-New Haven Hospital, Orange, CT.

Background: During the course of performing abdominoplasties, a plastic surgeon will encounter a certain body habitus characterized by a thick, tethered, and excessively redundant upper skin flap. Often these patients also demonstrate diffuse and substantial fascial laxity. One approach to this problem involves direct thinning and release of the flap by resection of the sub-Scarpa's fat pad. Read More

Aesthet Surg J 2019 Feb 5. Epub 2019 Feb 5.

Plastic Surgeon and Head of the in The Malopolska Center for Burns and Plastic Surgery, The Ludwik Rydygier Hospital, Krakow, Poland.

Background: The facial artery is the main blood vessel supplying the anterior face and an understanding of its anatomy is crucial in facial reconstruction and aesthetic procedures.

Objectives: The aim of this study was to assess the many anatomical features of the facial artery using a multidimensional approach.

Methods: Head and neck computed tomographic angiographies of 131 patients (255 facial arteries) with good image quality were evaluated. Read More

Aesthet Surg J 2019 Feb 5. Epub 2019 Feb 5.

Surgical nurse at a private plastic surgical practice in Eugene, OR.

Aesthet Surg J 2019 Jan 30. Epub 2019 Jan 30.

Division of Plastic Surgery, Baylor College of Medicine, Houston, TX.

Background: Providing residents with comprehensive training in aesthetic surgery has proven challenging. Resident aesthetic clinics propose an educational value to trainees while providing successful patient outcomes.

Objectives: This study systematically reviewed the available literature regarding resident aesthetic clinic outcomes to determine the efficacy of the clinic in resident training, surgical results, and patient satisfaction. Read More

Aesthet Surg J 2019 Feb 4. Epub 2019 Feb 4.

Universite Libre de Bruxelles, Brussels, Belgium.

Background: A simple and reproducible surgical technique for large volume fat grafting.

Objectives: The authors share their 7-year experience with their large volume fat transfer technique called power-assisted liposuction lipofilling (PALL).

Methods: our hundred and seventeen patients who underwent PALL related surgeries involving the breast and buttock were evaluated in a retrospective study. Read More

Aesthet Surg J 2019 Jan;39(Supplement_1):S36-S48

Department of Orthopedic Surgery, Rush University Medical Center, Chicago, IL.

Currently, there is a dearth of information regarding the degree of particle shedding from breast implants (BIs) and what are the general biological consequences of BI debris. Thus, it is unclear to what degree BI debris compromises the long-term biological performance of BIs. For orthopedic implants, it is well established that the severity of biological reactivity to implant debris governs long-term clinical performance. Read More

Aesthet Surg J 2019 Jan;39(Supplement_1):S1-S2

Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX.

Aesthet Surg J 2019 Jan;39(Supplement_1):S28-S35

Professor of Dermatology, Boston University School of Medicine and Roger Williams Medical Center, Providence, RI.

Cytokines, their receptors, and downstream signaling partners, especially JAK1/2 and STAT3, are key biomarkers in lymphoproliferative disorders including systemic anaplastic large cell lymphoma (ALCL). Here we review their role in breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). Early results suggest that, in addition to CD30, IL-9, IL-10, and IL-13 can distinguish malignant from benign seromas. Read More

Aesthet Surg J 2019 Jan;39(Supplement_1):S3-S13

Department of Hematology, Memorial Sloan Kettering Cancer Center, New York, NY.

National Comprehensive Cancer Network (NCCN) guidelines represent the consensus standard of care for diagnosis and management of the majority of known cancers. NCCN guidelines on breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) have been recognized by the US Food and Drug Administration and widely advocated by national specialty societies. Consensus guidelines have helped create a treatment standardization for BIA-ALCL at all stages of disease. Read More

Aesthet Surg J 2019 Jan;39(Supplement_1):S21-S27

Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge, UK.

The exact cellular origins of most malignancies are unknown, largely because of the complex nature of malignancies, and because the potential vast number of pathways towards transformation are difficult to discern from established growths. This is compounded by the fact that cancer cells have evolved rather than being the consequence of a design process, with most data collected from (sometimes epidemiological) studies of large numbers of related malignancies. In the case of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), the relative rarity of this disease, coupled with limited insight into its biological basis, have hampered progress. Read More

Aesthet Surg J 2019 Jan;39(Supplement_1):S49-S54

Plastic and Reconstructive Surgery Department, and Director of Lymph Clinic, Brussels University Hospital - Vrij Universiteit Brussel (VUB), Brussels, Belgium.

This article aims to present an overview on the use of polyurethane (PU) breast implants and the possible association with the risk of developing breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), with a special look at the current situation in Europe. It is well known that the real cause of BIA-ALCL remains unknown. Although this is a rare disease, many interesting theories surrounding its development have been advanced; however, none of these theories has been able to demonstrate with statistical significance, as required by the criteria of evidence-based medicine, definitive clinical proof as to why BIA-ALCL develops. Read More

Aesthet Surg J 2019 Jan;39(Supplement_1):S55-S65

Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.

Since their introduction into the market, breast implants have been the subject of many controversies. It is timely to examine the forces that have shaped the breast implant industry to make it what it is today. This review will concentrate more on the use of implants in aesthetic surgery rather than their use in breast reconstruction, but some of the factors have relevance to both indications. Read More

Aesthet Surg J 2019 Jan;39(Supplement_1):S14-S20

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.

Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), a newly included provisional entity in the 2016 revision of the World Health Organization classification, is a distinct form of CD30-positive T-cell non-Hodgkin lymphoma that arises in association with a breast implant after reconstructive or cosmetic surgery. In addition to its characteristic clinical presentation, recent studies using next-generation sequencing have revealed that BIA-ALCL has a unique pattern of genetic alterations. BIA-ALCL is consistently negative for ALCL-related gene rearrangements involving ALK, DUSP22, and TP63. Read More

Aesthet Surg J 2019 Feb 3. Epub 2019 Feb 3.

Department of Plastic Surgery, MD Anderson Cancer Center, Houston, TX.

Background: Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is an uncommon T-cell lymphoma associated with textured-surface breast implants. Human leukocyte antigen (HLA) polymorphisms have been described with other forms of lymphoma, but have not been described for BIA-ALCL.

Objectives: The aim of this study was to evaluate HLA polymorphisms in BIA-ALCL patients. Read More

Aesthet Surg J 2019 Jan 30. Epub 2019 Jan 30.

Saint Joseph University, Beirut, Lebanon.

Aesthet Surg J 2019 Jan 30. Epub 2019 Jan 30.

Division of Plastic Surgery, Department of Surgery, University of Wisconsin, Madison, WI.

Aesthet Surg J 2019 Jan 24. Epub 2019 Jan 24.

Resident, Division of Plastic Surgery and Reconstructive Surgery, University of Alberta, Edmonton, AB, Canada.

Aesthet Surg J 2019 Jan 23. Epub 2019 Jan 23.

Division of Plastic and Reconstructive Surgery, Northwestern Feinberg School of Medicine, Chicago, IL.

Background: The goal of upper eyelid procedures is to restore or create the ideal proportions between the pretarsal space and the upper lid fold.

Objectives: The aim of this study was to define the topographic features of the attractive upper lid.

Methods: Caucasian female frontal facial photographs were obtained from public media and periorbital areas were cropped. Read More

Aesthet Surg J 2019 Jan 23. Epub 2019 Jan 23.

Plastic surgeon in private practice in Santa Rosa, CA.

Aesthet Surg J 2019 Jan 21. Epub 2019 Jan 21.

Department of Plastic Surgery, Cleveland Clinic Foundation, Cleveland, OH.

Aesthet Surg J 2019 Jan 21. Epub 2019 Jan 21.

Division of Plastic Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.

Background: Lower blepharoplasty has been used for rejuvenating lower eyelids, and diverse modifications have been used to treat conjunct deformities at the tear trough/lid-cheek junction. Strategies for recontouring prominent tear trough/lid-cheek junctions, including orbital fat manipulation, have been reported with good results in the literature. Micro-autologous fat transplantation (MAFT) is a previously unevaluated, potentially advantageous approach to blending the prominent tear trough/lid-cheek junction. Read More

Aesthet Surg J 2019 Jan 22. Epub 2019 Jan 22.

Aesthet Surg J 2019 Jan;39(2):185-186

Department of Plastic Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA.

Aesthet Surg J 2019 Jan 17. Epub 2019 Jan 17.

Plastic surgeon in private practice in Kitchener, Ontario, Canada.

Aesthet Surg J 2019 Jan 14. Epub 2019 Jan 14.

Stanford University, CA, and a Plastic Surgery Specialist Registrar, London, UK.

Abdominal contour deformities are an aesthetic challenge to the plastic surgeon. Patients present with diverse clinical histories, multiple co-morbidities, and unique aesthetic demands. Weight loss, previous pregnancy, and aging are three principal indications for abdominoplasty. Read More

Aesthet Surg J 2019 Jan 11. Epub 2019 Jan 11.

Plastic surgeon in private practice in Athens, Greece.

Aesthet Surg J 2019 Jan 14. Epub 2019 Jan 14.

Department of Maxillofacial Plastic Surgery, Division of Dental and Maxillofacial Surgery and the Department of Public Health and Community Medicine, Unit of Epidemiology and Medical Statistics, G.B. Rossi Hospital and Medical University of Verona, Verona, Italy.

Background: The bad outcomes of a facial trauma could have a strongly negative psychological impact and compromise patient's quality of life. Unfortunately, surgery cannot always solve this problem or give an acceptable result.

Objectives: Aesthetic medicine treatments with injectables may provide a solution that is minimally invasive and more accepted by the patients in improving bad outcomes after facial trauma. Read More